VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 937-942

  Li, Dong ^a   Li, Xiang Pen ^a   Wang, Hong Xuan ^a   Shen, Qing Yu ^a   Li, Xiang Ping ^b   Wen, Lu ^a   Qin, Xiu Jiao ^a   Jia, Qiu Li ^a   Kung, Hsiang Fu ^a,c,d   Peng, Ying ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Angiogenesis; Glioma model; KDR; VEGF; Zebrafish

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; EMBRYO; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; XENOTRANSPLANTATION; ZEBRA FISH;

ALKALINE PHOSPHATASE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; EMBRYO, NONMAMMALIAN; GENE EXPRESSION; GLIOMA; HUMANS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84865347089     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1861     Document Type: Article

References (35)

1. Ng SS, Gao Y, Chau DH, et al: A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide. Cancer Gene Ther 14: 561-572, 2007.
2. Lin ZX, Yang LJ, Huang Q, et al: Inhibition of tumor-induced edema by antisense VEGF is mediated by suppressive vesiculo-vacuolar organelles (VVO) formation. Cancer Sci 99: 2540-2546, 2008.
3. Paez-Ribes M, Allen E, Hudock J, et al: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15: 220-231, 2009.
4. Norden AD, Drappatz J and Wen PY: Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 7: 1152-1160, 2008.
5. Vredenburgh JJ, Desjardins A, Herndon JN, et al: Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25: 4722-4729, 2007.
6. Tuettenberg J, Friedel C and Vajkoczy P: Angiogenesis in malignant glioma - a target for antitumor therapy? Crit Rev Oncol Hematol 59: 181-193, 2006.
7. Gan HK, Lappas M, Cao DX, Cvrljevdic A, Scott AM and Johns TG: Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization. J Cell Mol Med 13: 3993-4001, 2009.
8. Jang FF, Wei W and De WM: Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma. J Ayub Med Coll Abbottabad 20: 105-109, 2008.
9. di Tomaso E, London N, Fuja D, et al: PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment. PLoS One 4: e5123, 2009.
10. Huse JT and Holland EC: Genetically engineered mouse models of brain cancer and the promise of preclinical testing. Brain Pathol 19: 132-143, 2009.
11. Lee LM, Seftor EA, Bonde G, Cornell RA and Hendrix MJ: The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233: 1560-1570, 2005.
12. Stoletov K, Montel V, Lester RD, Gonias SL and Klemke R: High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 104: 17406-17411, 2007.
13. Jesuthasan S: Genetics and development. Zebrafish in the spotlight. Science 297: 1484-1485, 2002.
14. Stoletov K and Klemke R: Catch of the day: zebrafish as a human cancer model. Oncogene 27: 4509-4520, 2008.
15. White RM, Sessa A, Burke C, et al: Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2: 183-189, 2008.
16. Cross LM, Cook MA, Lin S, Chen JN and Rubinstein AL: Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol 23: 911-912, 2003.
17. Westerfield M: The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). Eugene, OR, University of Oregon Press, 2007.
18. Nicoli S, Ribatti D, Cotelli F and Presta M: Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 67: 2927-2931, 2007.
19. Nicoli S and Presta M: The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2: 2918-2923, 2007.
20. Serbedzija GN, Flynn E and Willett CE: Zebrafish angiogenesis: a new model for drug screening. Angiogenesis 3: 353-359, 1999.
21. Thisse C and Thisse B: High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3: 59-69, 2008.
22. Adhikary S and Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645, 2005.
23. Spitsbergen JM, Tsai HW, Reddy A, et al: Neoplasia in zebrafish (danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol Pathol 28: 705-715, 2000.
24. Spitsbergen JM, Tsai HW, Reddy A, et al: Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 28: 716-725, 2000.
25. Shepard JL, Amatruda JF, Stern HM, et al: A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci USA 102: 13194-13199, 2005.
26. Amatruda JF, Shepard JL, Stern HM and Zon LI: Zebrafish as a cancer model system. Cancer Cell 1: 229-231, 2002.
27. Mione MC and Trede NS: The zebrafish as a model for cancer. Dis Model Mech 3: 517-523, 2010.
28. Chi A, Norden AD and Wen PY: Inhibition of angiogenesis and invasion in malignant gliomas. Expert Rev Anticancer Ther 7: 1537-1560, 2007.
29. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
30. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
31. Roy H, Bhardwaj S and Yla-Herttuala S: Biology of vascular endothelial growth factors. FEBS Lett 580: 2879-2887, 2006.
32. Neufeld G, Tessler S, Gitay-Goren H, Cohen T and Levi BZ: Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5: 89-97, 1994.
33. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
34. Habeck H, Odenthal J, Walderich B, Maischein H and Schulte-Merker S: Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr Biol 12: 1405-1412, 2002.
35. Liang D, Xu X, Chin AJ, et al: Cloning and characterization of vascular endothelial growth factor (VEGF) from zebrafish, Danio rerio. Biochim Biophys Acta 1397: 14-20, 1998.